Cargando…

α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice

Alzheimer's disease (AD) is the most common neurodegenerative disease and is characterized by neurofibrillary tangles (NFTs) composed of Tau protein. α-Lipoic acid (LA) has been found to stabilize the cognitive function of AD patients, and animal study findings have confirmed its anti-amyloidog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yan-Hui, Wang, Da-Wei, Xu, Shuang-Feng, Zhang, Shuai, Fan, Yong-Gang, Yang, Ying-Ying, Guo, Shi-Qi, Wang, Shan, Guo, Tian, Wang, Zhan-You, Guo, Chuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684493/ https://www.ncbi.nlm.nih.gov/pubmed/29126071 http://dx.doi.org/10.1016/j.redox.2017.11.001

Ejemplares similares

Tauopathy-induced retinal dysfunction in the P301S mutant human tau transgenic mouse
por: Mazzaro, Nadia, et al.
Publicado: (2013)

Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling
por: Zaki, Mennatallah O., et al.
Publicado: (2022)

Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
por: Hosokawa, Masato, et al.
Publicado: (2012)

P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating
por: Takeuchi, Hiroki, et al.
Publicado: (2011)

Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
por: Ozcelik, Sefika, et al.
Publicado: (2013)

Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy
por: Williams, Tristan, et al.
Publicado: (2023)

Organotypic Brain Slice Cultures of Adult Transgenic P301S Mice—A Model for Tauopathy Studies
por: Mewes, Agneta, et al.
Publicado: (2012)

Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
por: Theunis, Clara, et al.
Publicado: (2013)

Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice
por: Höllerhage, Matthias, et al.
Publicado: (2014)

Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice
por: Zhong, Suyue, et al.
Publicado: (2023)

TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits12
por: Wang, Hongjie, et al.
Publicado: (2016)

α-Lipoic Acid Maintains Brain Glucose Metabolism via BDNF/TrkB/HIF-1α Signaling Pathway in P301S Mice
por: Zhang, Yan-hui, et al.
Publicado: (2020)

Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice
por: Ohia-Nwoko, Odochi, et al.
Publicado: (2014)

Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice
por: Clavaguera, Florence, et al.
Publicado: (2013)

Phospho-Tau Accumulation and Structural Alterations of the Golgi Apparatus of Cortical Pyramidal Neurons in the P301S Tauopathy Mouse Model
por: Antón-Fernández, Alejandro, et al.
Publicado: (2017)

Chronic Sleep Disruption Advances the Temporal Progression of Tauopathy in P301S Mutant Mice
por: Zhu, Yan, et al.
Publicado: (2018)

Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice
por: Hoffmann, Nadine A, et al.
Publicado: (2013)

Correction: Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice
Publicado: (2015)

Altered sleep and EEG power in the P301S Tau transgenic mouse model
por: Holth, Jerrah K., et al.
Publicado: (2017)

Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy
por: Arouche-Delaperche, L., et al.
Publicado: (2023)

Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
por: Smolek, Tomas, et al.
Publicado: (2019)

The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice
por: Davidowitz, Eliot J., et al.
Publicado: (2023)

Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic Mice
por: Schön, Christian, et al.
Publicado: (2012)

Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord
por: Macdonald, Jennifer A., et al.
Publicado: (2019)

Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
por: Bi, Mian, et al.
Publicado: (2011)

Biochemical Distribution of Tau Protein in Synaptosomal Fraction of Transgenic Mice Expressing Human P301L Tau
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau
por: Schweighauser, Manuel, et al.
Publicado: (2023)

Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer’s disease
por: Bennett, Rachel E., et al.
Publicado: (2018)

Structural MRI Reveals Cervical Spinal Cord Atrophy in the P301L Mouse Model of Tauopathy: Gender and Transgene-Dosing Effects
por: Sartoretti, Thomas, et al.
Publicado: (2022)

Correction to: The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
por: Smolek, Tomas, et al.
Publicado: (2020)

VPS35 regulates tau phosphorylation and neuropathology in tauopathy
por: Vagnozzi, Alana N., et al.
Publicado: (2021)

Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies
por: Tong, Benjamin Chun-Kit, et al.
Publicado: (2022)

Transcellular Spreading of Tau in Tauopathies
por: Demaegd, Koen, et al.
Publicado: (2018)

Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
por: Eckenweber, Florian, et al.
Publicado: (2020)

Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
por: Valencia, Antonio, et al.
Publicado: (2021)

Alteration in the Synaptic and Extrasynaptic Organization of AMPA Receptors in the Hippocampus of P301S Tau Transgenic Mice
por: Alfaro-Ruiz, Rocio, et al.
Publicado: (2022)

Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
por: Chang, Yanmin, et al.
Publicado: (2021)

Anterograde and Retrograde Propagation of Inoculated Human Tau Fibrils and Tau Oligomers in a Non-Transgenic Rat Tauopathy Model
por: Langer Horvat, Lea, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_paakb6o4jdoillh0216bg9qpgq